Antibiotic Use before, during, and after Seeking Care for Acute Febrile Illness at a Hospital Outpatient Department: A Cross-Sectional Study from Rural India.

Bronwen Holloway, Harshitha Chandrasekar, Manju Purohit, Ashish Sharma, Aditya Mathur, Ashish Kc, Leticia Fernandez-Carballo, Sabine Dittrich, Helena Hildenwall, Anna Bergström
Author Information
  1. Bronwen Holloway: Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden. ORCID
  2. Harshitha Chandrasekar: Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden.
  3. Manju Purohit: Department of Pathology, Ruxmaniben Deepchand Gardi Medical College, Ujjain 456006, India.
  4. Ashish Sharma: Department of Medicine, Ruxmaniben Deepchand Gardi Medical College, Ujjain 456006, India.
  5. Aditya Mathur: Department of Paediatrics, Ruxmaniben Deepchand Gardi Medical College, Ujjain 456006, India. ORCID
  6. Ashish Kc: Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden.
  7. Leticia Fernandez-Carballo: Foundation for Innovative New Diagnostics, 1202 Geneva, Switzerland.
  8. Sabine Dittrich: Foundation for Innovative New Diagnostics, 1202 Geneva, Switzerland.
  9. Helena Hildenwall: Department of Global Public Health, Health Systems and Policy, Karolinska Institute, 171 77 Stockholm, Sweden.
  10. Anna Bergström: Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden.

Abstract

Antibiotic resistance is a naturally occurring phenomenon, but the misuse and overuse of antibiotics is accelerating the process. This study aimed to quantify and compare antibiotic use before, during, and after seeking outpatient care for acute febrile illness in Ujjain, India. Data were collected through interviews with patients/patient attendants. The prevalence and choice of antibiotics is described by the WHO AWaRe categories and Anatomical Therapeutic Chemical classes, comparing between age groups. Units of measurement include courses, encounters, and Defined Daily Doses (DDDs). The antibiotic prescription during the outpatient visit was also described in relation to the patients' presumptive diagnosis. Of 1000 included patients, 31.1% ( = 311) received one antibiotic course, 8.1% ( = 81) two, 1.3% ( = 13) three, 0.4% ( = 4) four, 0.1% ( = 1) five, and the remaining 59.0% ( = 590) received no antibiotics. The leading contributors to the total antibiotic volume in the DDDs were macrolides (30.3%), combinations of penicillins, including β-lactamase inhibitors (18.8%), tetracyclines (14.8%), fluoroquinolones (14.6%), and third-generation cephalosporins (13.7%). 'Watch' antibiotics accounted for 72.3%, 52.7%, and 64.0% of encounters before, during, and after the outpatient visit, respectively. Acute viral illness accounted for almost half of the total DDDs at the outpatient visit (642.1/1425.3, 45.1%), for which the macrolide antibiotic azithromycin was the most frequently prescribed antibiotic (261.3/642.1, 40.7%).

Keywords

References

  1. PLoS One. 2016 Jan 28;11(1):e0146054 [PMID: 26821179]
  2. JAC Antimicrob Resist. 2020 Sep;2(3):dlaa048 [PMID: 32974610]
  3. Glob Health Res Policy. 2017 May 08;2:14 [PMID: 29202082]
  4. Infect Chemother. 2014 Dec;46(4):226-38 [PMID: 25566402]
  5. BMJ Glob Health. 2020 Sep;5(9): [PMID: 32938614]
  6. BMJ Open. 2020 Nov 26;10(11):e041087 [PMID: 33243808]
  7. PLoS Med. 2015 May 12;12(5):e1001826; discussion e1001826 [PMID: 25965416]
  8. PLoS One. 2019 Aug 1;14(8):e0220316 [PMID: 31369610]
  9. Antibiotics (Basel). 2019 Sep 05;8(3): [PMID: 31491900]
  10. Nat Microbiol. 2019 Jan;4(1):46-54 [PMID: 30546093]
  11. Clin Microbiol Infect. 2021 Sep;27(9):1293-1300 [PMID: 33188934]
  12. Nat Med. 2019 Sep;25(9):1370-1376 [PMID: 31406349]
  13. Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S285-S292 [PMID: 33258935]
  14. J Pediatr. 2020 May;220:125-131.e5 [PMID: 32093934]
  15. BMC Infect Dis. 2020 May 13;20(1):340 [PMID: 32404055]
  16. Pharm Pract (Granada). 2021 Jan-Mar;19(1):2206 [PMID: 33828621]
  17. Br J Clin Pharmacol. 2019 Jan;85(1):59-70 [PMID: 29397576]
  18. Indian J Med Res. 2019 Feb;149(2):87-96 [PMID: 31219073]
  19. Clin Infect Dis. 2018 May 2;66(10):1602-1609 [PMID: 29211830]
  20. Health Policy. 2004 May;68(2):211-22 [PMID: 15063020]
  21. PLoS One. 2021 Jan 20;16(1):e0241899 [PMID: 33471786]
  22. Int J Infect Dis. 2020 Jul;96:334-342 [PMID: 32437937]
  23. Scand J Infect Dis. 2011 Jul;43(6-7):479-88 [PMID: 21299365]
  24. J Perinatol. 2016 Dec;36(s3):S9-S12 [PMID: 27924110]
  25. Rev Environ Contam Toxicol. 2007;191:131-62 [PMID: 17708074]
  26. Indian J Med Res. 2011 Nov;134(5):627-38 [PMID: 22199101]
  27. Antimicrob Agents Chemother. 2006 Nov;50(11):3646-50 [PMID: 16940064]
  28. Lancet Infect Dis. 2019 Jan;19(1):67-75 [PMID: 30522834]
  29. PLoS Med. 2016 Mar 02;13(3):e1001974 [PMID: 26934098]
  30. BMJ. 2021 Feb 26;372:n437 [PMID: 33637488]

Grants

  1. SLS-776141/Swedish Society of Medicine
  2. N/A/InDevelops u-landsfond
  3. N/A/Uppsala University
  4. N/A/Rönnows Foundation travel scholarships

Word Cloud

Created with Highcharts 10.0.0antibiotic=antibioticsoutpatient1%illnessIndiaDDDsvisit13%7%AntibioticresistanceuseacutefebriledescribedAWaReencountersreceived1300%total8%14accountedAcutenaturallyoccurringphenomenonmisuseoveruseacceleratingprocessstudyaimedquantifycompareseekingcareUjjainDatacollectedinterviewspatients/patientattendantsprevalencechoiceWHOcategoriesAnatomicalTherapeuticChemicalclassescomparingagegroupsUnitsmeasurementincludecoursesDefinedDailyDosesprescriptionalsorelationpatients'presumptivediagnosis1000includedpatients31311onecourse881twothree4%4fourfiveremaining59590leadingcontributorsvolumemacrolides30combinationspenicillinsincludingβ-lactamaseinhibitors18tetracyclinesfluoroquinolones6%third-generationcephalosporins'Watch'725264respectivelyviralalmosthalf6421/1425345macrolideazithromycinfrequentlyprescribed2613/64240UseSeekingCareFebrileIllnessHospitalOutpatientDepartment:Cross-SectionalStudyRuralaccessexcessfeverlow-middle-incomecountriesruralpopulation

Similar Articles

Cited By